Red blood cell wide variety of endogenous mediators and xenobiotics. Excessive eryptosis is observed in red blood cells lacking the cGMP-dependent protein kinase type I or the AMP-activated protein kinase AMPK. Inhibitors of eryptosis include erythropoietin, nitric oxide, catecholamines and high concentrations of urea. Much of the resulting breakdown products are recirculated in the body. The heme constituent of hemoglobin are broken down into iron (Fe) and biliverdin. The biliverdin is reduced to bilirubin, which is released into the plasma and recirculated to the liver bound to albumin. The iron is released into the plasma to be recirculated by a carrier protein called
Packed red blood cells as anaphylaxis, red blood cell breakdown, infection, volume overload, and lung injury. With current preparation methods in the developed world the risk of viral infections such as hepatitis C and HIV/AIDS are less than one in a million. However, the risks of infection are higher in low income countries. Packed red blood cells are produced from whole blood or by apheresis. They typically last for three to six weeks. The widespread use of packed red blood cells began in the 1960s. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in